Kenny Walter

Multiple studies have found a decrease in CDI rates during the COVID-19 pandemic in comparison to previous years.

Esophageal cancer has a low survival rate largely due to advanced stage diagnosis.

A large proportion of IBS-C patients did not seek health care during the COVID-19 pandemic despite symptoms.

Arena Pharmaceuticals expects to move forward with later phase clinical trials testing etrasimod.

Direct optical endoscopy are often underutilized in screenings for EAC.

Dr. Evan Dellon said up to 8 biopsies for high risk patients could be beneficial in diagnosing different diseases impacting the esophagus.

COVID-19 patients with liver injuries are at a higher risk of mortality or lengthier hospital stays.

Most of the data on vedolizumab has been limited by small sample sizes and short follow-up.

About a quarter of Cologuard's ordered by patients are deemed to be inappropriate.

Infections in patients with ulcerative colitis treated with ozanimod were mostly characterized as non-serious.

The treatment would represent the first microbiota-based live biotherapeutic to show efficacy in the first recurrence of CDI.

Ulcerative colitis patients with fatigue are more likely to be unemployed, have moderate or severe disease, and higher Mayo scores.

C difficile and sepsis infections can be especially difficult to treat.

SER-109 resulted in a 73% reduction in relative risk for CDI over 8 weeks.

There is a substantial health care cost for CDI patients with sepsis.

In data presented at DDW, researchers find a decrease in hospital-acquired CDI infections in 2020 when compared to 2018 and 2019.

Veterans are particularly susceptible to opioid dependence and abuse.

The researchers developed a computerized clinical decision support tool to help clinicians prescribe probiotics.

A large proportion of HCV patients remain undiagnosed, particularly in the older population.

Vonoprazan has shown more potent acid inhibitory effects than PPI.

Pegcetacoplan outperformed competitor in a phase 3 head-to-head study.

Vaccinated individuals no longer need to wear masks indoors in accordance with CDC guidance.

FIX activity was similar in participants without and with pre-existing neutralizing antibodies.

An electronic reminding system helped identify 3783 patients with anti-HCV antibody documentation.

There was no significant association between uric acid levels and incident stroke.

Bayer has submitted a New Drug Application for the mineralocorticoid receptor antagonist.

The presence of extra-intestinal manifestations in biologic-naïve anti-TNF patients with Crohn’s disease was a predictor of disease severity.

The majority of adverse effects reported were considered mild.

More than 40% of the treatment arm of the placebo-controlled trial achieved a complete renal response.

Histologic scores in the endoscopically involved mucosa of index biopsies not linked to subsequent extension of ulcerative colitis.